Global Genomics Market Projected to Grow at a CAGR of 13.2% over the Forecast Period 2017-2025

New York, USA, 2018-Aug-31 — /EPR Network/ —Global genome editing market is propelled by the number of factors such as increasing government funding for genome projects, technological advancement, the high prevalence of cancer & other infectious diseases. According to Goldstein Research, global genome market size is expected to reach USD 8.56 billion by 2025, growing at a compounded annual growth rate of 13.2% during the forecast period 2017-2025.

Moreover, the growth of global genome editing market has direct implications, which is growing at a CAGR of 11.2% during the forecast period. Global genome editing market segmentation has been carried out on the basis of technology, application, end user, and geography. On the basis of technology, CRISPR segment accounted for the largest market share of 45% in 2017. Whereas, based on application, cell line engineering segment in 2017 is leading the genome engineering market.

Further, Global genome editing industry is estimated to be dominated by North America with a market share of 35.25% in 2017. Whereas, Asia Pacific region is expected to be most opportunistic & fastest developing region for the growth of genome editing industry due to increasing government focus on the field of genomics. Further, Europe accounts for substantial market share due to the presence of key players in the region.

 Download Exclusive Sample Report:

Market Segmentation

On the basis of our in-depth analysis, Global Genome EditingMarketcan is segmented as follows:

By Technology

  • CRISPR (Clustered Regularly Interspersed Short Palindromic Repeats)
  • ZFN
  • Other ((PiggyBac, Flp-In, Adenine Base Editor (ADE), Antisense and Jump-In)

By Application

  • Cell Line Engineering
  • Animal Genetic Engineering
  • Plant Genetic Engineering

By End User

  • Biotechnology & Pharmaceutical Companies
  • CROs

By Region

  • North America (US, Canada) {Market Share (%), Market Size (USD Billion, Adoption Rate (%)}
  • Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
  • The Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of the Middle East & Africa) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
  • Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
  • Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
  • Rest of the World {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}

Browse Full Report:

“Global Genome Editing Market Outlook 2025” contains a detailed overview of the global genome editing market. On the basis of our in-depth analysis, the market can be segmented in terms of market segmentation by technology, application, and end user.

Further, for the in-depth analysis, Global Genome Editing Market Report encompasses the market growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis. This market analysis report also includes competitive outlook of some of the major players profiling of companies such as Horizon Discovery Group plc, Thermo Fisher Scientific, Merck, Horizon Discovery Group, GenScript, SangamoBioSciences, Integrated DNA Technologies, Lonza Group, New England Biolabs, OriGene Technologies, Transposagen Biopharmaceuticals, Editas Medicine, CRISPR Therapeutics,etc.

The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services, and industries catered, financial analysis of the company and recent developments.

Overall, the report represents the global genome editing market trends along with the market forecast that will help market consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.

Key questions answered in this Global Genome Editing Market Report

  • What is the Global Genome Editing Market Size by 2025 and what would be the expected growth rate of the market?
  • What is the total revenue per segment and region in 2016-17 and what would be the expected revenue per segment and region over the forecast period?
  • What is the genome editing market trends?
  • What are the factors which are driving this market?
  • What are the major barriers to genome editing market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities for the existing and entry-level players?
  • What are the recent developments and business strategy of the key players?

About Goldstein Research

Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.

Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts.

Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview. Our analysts working on healthcare market analysis reports helping various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in the rigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable for our clients’ needs and business agenda.

Contact for more Info:

Steve Blade

(Global Sales Head)

USA: + 1-646-568-7747

Canada: 1-437-886-1181

UK: +44-203-318-6627

Browse Similar Report: Global Genomics Market


Matched content

Editor’s pick

Express Press Release Distribution